These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12952914)

  • 1. The host response to anthrax lethal toxin: unexpected observations.
    Prince AS
    J Clin Invest; 2003 Sep; 112(5):656-8. PubMed ID: 12952914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of anthrax toxin in pathogenesis.
    Moayeri M; Leppla SH
    Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.
    Kuo SR; Willingham MC; Bour SH; Andreas EA; Park SK; Jackson C; Duesbery NS; Leppla SH; Tang WJ; Frankel AE
    Microb Pathog; 2008 Jun; 44(6):467-72. PubMed ID: 18222626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity.
    Moayeri M; Martinez NW; Wiggins J; Young HA; Leppla SH
    Infect Immun; 2004 Aug; 72(8):4439-47. PubMed ID: 15271901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.
    Cui X; Li Y; Li X; Laird MW; Subramanian M; Moayeri M; Leppla SH; Fitz Y; Su J; Sherer K; Eichacker PQ
    J Infect Dis; 2007 Feb; 195(4):572-80. PubMed ID: 17230417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.
    Moayeri M; Haines D; Young HA; Leppla SH
    J Clin Invest; 2003 Sep; 112(5):670-82. PubMed ID: 12952916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine enhances survival in Bacillus anthracis intoxication.
    Artenstein AW; Opal SM; Cristofaro P; Palardy JE; Parejo NA; Green MD; Jhung JW
    J Infect Dis; 2004 Nov; 190(9):1655-60. PubMed ID: 15478072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin.
    Kassam A; Der SD; Mogridge J
    Cell Microbiol; 2005 Feb; 7(2):281-92. PubMed ID: 15659071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical genetic screening identifies critical pathways in anthrax lethal toxin-induced pathogenesis.
    Panchal RG; Ruthel G; Brittingham KC; Lane D; Kenny TA; Gussio R; Lazo JS; Bavari S
    Chem Biol; 2007 Mar; 14(3):245-55. PubMed ID: 17379140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection.
    Cleret A; Quesnel-Hellmann A; Mathieu J; Vidal D; Tournier JN
    J Infect Dis; 2006 Jul; 194(1):86-94. PubMed ID: 16741886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of lethal and edema factors in rabbit systemic anthrax.
    Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
    Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B.
    Gutting BW; Gaske KS; Schilling AS; Slaterbeck AF; Sobota L; Mackie RS; Buhr TL
    Toxicol In Vitro; 2005 Mar; 19(2):221-9. PubMed ID: 15649636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets.
    Kau JH; Sun DS; Tsai WJ; Shyu HF; Huang HH; Lin HC; Chang HH
    J Infect Dis; 2005 Oct; 192(8):1465-74. PubMed ID: 16170766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.
    Banks DJ; Barnajian M; Maldonado-Arocho FJ; Sanchez AM; Bradley KA
    Cell Microbiol; 2005 Aug; 7(8):1173-85. PubMed ID: 16008584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
    Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ
    Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.